FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.4  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Metformin hydrochloride 850 mg and vildagliptin 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely sitagliptin (as sitagliptin hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely sitagliptin (as sitagliptin hydrochloride) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Sitagliptin (as sitagliptin hydrochloride) 50 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Sitagliptin (as sitagliptin hydrochloride) 50 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely sitagliptin (as sitagliptin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely sitagliptin (as sitagliptin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram and saxagliptin (as saxagliptin hydrochloride) 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 2
Product containing precisely pitavastatin (as pitavastatin calcium) 4 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely pitavastatin (as pitavastatin calcium) 4 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lurasidone (as lurasidone hydrochloride) 37.2 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Lurasidone (as lurasidone hydrochloride) 37.2 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lurasidone (as lurasidone hydrochloride) 74.5 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Lurasidone (as lurasidone hydrochloride) 74.5 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Lurasidone (as lurasidone hydrochloride) 18.6 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Lurasidone (as lurasidone hydrochloride) 18.6 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely pitavastatin (as pitavastatin calcium) 2 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely pitavastatin (as pitavastatin calcium) 2 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1
Product containing precisely pitavastatin (as pitavastatin calcium) 1 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Some
Product containing precisely pitavastatin (as pitavastatin calcium) 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Some 1

Start Previous Page 84 of 84

This concept is not in any reference sets

Back to Start